Drug intelligence / Profile preview

Jianpi Jiedu pill

Development stage: Preclinical
Lead developer: Xinjiang Uygur Autonomous Region Chinese Medicine Hospital
Modality: Small Molecules
Administration: Oral

Overview

Jianpi Jiedu pill is a Traditional Chinese Medicine (TCM) formula currently undergoing clinical evaluation for the treatment of psoriasis vulgaris. In the context of TCM, 'Jianpi' signifies strengthening the spleen, which is believed to enhance digestive function and overall bodily vitality, while 'Jiedu' denotes detoxifying, suggesting anti-inflammatory and pathogen-eliminating properties. Its therapeutic effects in psoriasis are thought to stem from immunomodulatory and anti-inflammatory actions.

Other names: 健脾解毒丸

Beyond the preview

Go deeper on Jianpi Jiedu pill.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Jianpi Jiedu pill.

Explore the full profile